Global Drug Coated Coronary Balloon Catheter Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Drug Coated Coronary Balloon Catheter market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Drug Coated Coronary Balloon Catheter is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Drug Coated Coronary Balloon Catheter is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Drug Coated Coronary Balloon Catheter is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Drug Coated Coronary Balloon Catheter is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Drug Coated Coronary Balloon Catheter include B.Braun, BD, Biotronik, Bonston Scientific, Concept Medical Inc, Eurocor Tech GmbH, Medronic, USM Healthcare and Zhejiang Barty Medical Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Drug Coated Coronary Balloon Catheter, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Drug Coated Coronary Balloon Catheter, also provides the sales of main regions and countries. Of the upcoming market potential for Drug Coated Coronary Balloon Catheter, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Coated Coronary Balloon Catheter sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Drug Coated Coronary Balloon Catheter market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Drug Coated Coronary Balloon Catheter sales, projected growth trends, production technology, application and end-user industry.

Drug Coated Coronary Balloon Catheter Segment by Company

B.Braun
BD
Biotronik
Bonston Scientific
Concept Medical Inc
Eurocor Tech GmbH
Medronic
USM Healthcare
Zhejiang Barty Medical Technology
Blue Sail Medical
Lepu Medical Technology
Yinyi (Liaoning) Biotech
MicroPort
Acotec Scientific
GrandPharma(Cardionovum)
Drug Coated Coronary Balloon Catheter Segment by Type

Sirolimus
Beautiful Moss
Paclitaxel
Others
Drug Coated Coronary Balloon Catheter Segment by Application

Hospital
Clinic
Others
Drug Coated Coronary Balloon Catheter Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Coated Coronary Balloon Catheter market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Coated Coronary Balloon Catheter and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Coated Coronary Balloon Catheter.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug Coated Coronary Balloon Catheter market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Coated Coronary Balloon Catheter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Coated Coronary Balloon Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Drug Coated Coronary Balloon Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Drug Coated Coronary Balloon Catheter Market Size, 2020 VS 2024 VS 2031
1.3 Global Drug Coated Coronary Balloon Catheter Market Size Estimates and Forecasts (2020-2031)
1.4 Global Drug Coated Coronary Balloon Catheter Sales Estimates and Forecasts (2020-2031)
1.5 Global Drug Coated Coronary Balloon Catheter Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Drug Coated Coronary Balloon Catheter Market Dynamics
2.1 Drug Coated Coronary Balloon Catheter Industry Trends
2.2 Drug Coated Coronary Balloon Catheter Industry Drivers
2.3 Drug Coated Coronary Balloon Catheter Industry Opportunities and Challenges
2.4 Drug Coated Coronary Balloon Catheter Industry Restraints
3 Drug Coated Coronary Balloon Catheter Market by Manufacturers
3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Manufacturers (2020-2025)
3.2 Global Drug Coated Coronary Balloon Catheter Sales by Manufacturers (2020-2025)
3.3 Global Drug Coated Coronary Balloon Catheter Average Sales Price by Manufacturers (2020-2025)
3.4 Global Drug Coated Coronary Balloon Catheter Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Drug Coated Coronary Balloon Catheter Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Drug Coated Coronary Balloon Catheter Manufacturers, Product Type & Application
3.7 Global Drug Coated Coronary Balloon Catheter Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Drug Coated Coronary Balloon Catheter Market CR5 and HHI
3.8.2 Global Top 5 and 10 Drug Coated Coronary Balloon Catheter Players Market Share by Revenue in 2024
3.8.3 2024 Drug Coated Coronary Balloon Catheter Tier 1, Tier 2, and Tier 3
4 Drug Coated Coronary Balloon Catheter Market by Type
4.1 Drug Coated Coronary Balloon Catheter Type Introduction
4.1.1 Sirolimus
4.1.2 Beautiful Moss
4.1.3 Paclitaxel
4.1.4 Others
4.2 Global Drug Coated Coronary Balloon Catheter Sales by Type
4.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Drug Coated Coronary Balloon Catheter Sales by Type (2020-2031)
4.2.3 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2020-2031)
4.3 Global Drug Coated Coronary Balloon Catheter Revenue by Type
4.3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Drug Coated Coronary Balloon Catheter Revenue by Type (2020-2031)
4.3.3 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2020-2031)
5 Drug Coated Coronary Balloon Catheter Market by Application
5.1 Drug Coated Coronary Balloon Catheter Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Drug Coated Coronary Balloon Catheter Sales by Application
5.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Drug Coated Coronary Balloon Catheter Sales by Application (2020-2031)
5.2.3 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2020-2031)
5.3 Global Drug Coated Coronary Balloon Catheter Revenue by Application
5.3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Drug Coated Coronary Balloon Catheter Revenue by Application (2020-2031)
5.3.3 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2020-2031)
6 Global Drug Coated Coronary Balloon Catheter Sales by Region
6.1 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Drug Coated Coronary Balloon Catheter Sales by Region (2020-2031)
6.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Region (2020-2025)
6.2.2 Global Drug Coated Coronary Balloon Catheter Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Drug Coated Coronary Balloon Catheter Revenue by Region
7.1 Global Drug Coated Coronary Balloon Catheter Revenue by Region
7.1.1 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Drug Coated Coronary Balloon Catheter Revenue by Region (2020-2025)
7.1.3 Global Drug Coated Coronary Balloon Catheter Revenue by Region (2026-2031)
7.1.4 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Drug Coated Coronary Balloon Catheter Revenue (2020-2031)
7.2.2 North America Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Drug Coated Coronary Balloon Catheter Revenue (2020-2031)
7.3.2 Europe Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Drug Coated Coronary Balloon Catheter Revenue (2020-2031)
7.4.2 Asia-Pacific Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 B.Braun
8.1.1 B.Braun Comapny Information
8.1.2 B.Braun Business Overview
8.1.3 B.Braun Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 B.Braun Drug Coated Coronary Balloon Catheter Product Portfolio
8.1.5 B.Braun Recent Developments
8.2 BD
8.2.1 BD Comapny Information
8.2.2 BD Business Overview
8.2.3 BD Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 BD Drug Coated Coronary Balloon Catheter Product Portfolio
8.2.5 BD Recent Developments
8.3 Biotronik
8.3.1 Biotronik Comapny Information
8.3.2 Biotronik Business Overview
8.3.3 Biotronik Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Biotronik Drug Coated Coronary Balloon Catheter Product Portfolio
8.3.5 Biotronik Recent Developments
8.4 Bonston Scientific
8.4.1 Bonston Scientific Comapny Information
8.4.2 Bonston Scientific Business Overview
8.4.3 Bonston Scientific Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Bonston Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
8.4.5 Bonston Scientific Recent Developments
8.5 Concept Medical Inc
8.5.1 Concept Medical Inc Comapny Information
8.5.2 Concept Medical Inc Business Overview
8.5.3 Concept Medical Inc Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Concept Medical Inc Drug Coated Coronary Balloon Catheter Product Portfolio
8.5.5 Concept Medical Inc Recent Developments
8.6 Eurocor Tech GmbH
8.6.1 Eurocor Tech GmbH Comapny Information
8.6.2 Eurocor Tech GmbH Business Overview
8.6.3 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Product Portfolio
8.6.5 Eurocor Tech GmbH Recent Developments
8.7 Medronic
8.7.1 Medronic Comapny Information
8.7.2 Medronic Business Overview
8.7.3 Medronic Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Medronic Drug Coated Coronary Balloon Catheter Product Portfolio
8.7.5 Medronic Recent Developments
8.8 USM Healthcare
8.8.1 USM Healthcare Comapny Information
8.8.2 USM Healthcare Business Overview
8.8.3 USM Healthcare Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 USM Healthcare Drug Coated Coronary Balloon Catheter Product Portfolio
8.8.5 USM Healthcare Recent Developments
8.9 Zhejiang Barty Medical Technology
8.9.1 Zhejiang Barty Medical Technology Comapny Information
8.9.2 Zhejiang Barty Medical Technology Business Overview
8.9.3 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
8.9.5 Zhejiang Barty Medical Technology Recent Developments
8.10 Blue Sail Medical
8.10.1 Blue Sail Medical Comapny Information
8.10.2 Blue Sail Medical Business Overview
8.10.3 Blue Sail Medical Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Blue Sail Medical Drug Coated Coronary Balloon Catheter Product Portfolio
8.10.5 Blue Sail Medical Recent Developments
8.11 Lepu Medical Technology
8.11.1 Lepu Medical Technology Comapny Information
8.11.2 Lepu Medical Technology Business Overview
8.11.3 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
8.11.5 Lepu Medical Technology Recent Developments
8.12 Yinyi (Liaoning) Biotech
8.12.1 Yinyi (Liaoning) Biotech Comapny Information
8.12.2 Yinyi (Liaoning) Biotech Business Overview
8.12.3 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Product Portfolio
8.12.5 Yinyi (Liaoning) Biotech Recent Developments
8.13 MicroPort
8.13.1 MicroPort Comapny Information
8.13.2 MicroPort Business Overview
8.13.3 MicroPort Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 MicroPort Drug Coated Coronary Balloon Catheter Product Portfolio
8.13.5 MicroPort Recent Developments
8.14 Acotec Scientific
8.14.1 Acotec Scientific Comapny Information
8.14.2 Acotec Scientific Business Overview
8.14.3 Acotec Scientific Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Acotec Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
8.14.5 Acotec Scientific Recent Developments
8.15 GrandPharma(Cardionovum)
8.15.1 GrandPharma(Cardionovum) Comapny Information
8.15.2 GrandPharma(Cardionovum) Business Overview
8.15.3 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Product Portfolio
8.15.5 GrandPharma(Cardionovum) Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Drug Coated Coronary Balloon Catheter Value Chain Analysis
9.1.1 Drug Coated Coronary Balloon Catheter Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Drug Coated Coronary Balloon Catheter Production Mode & Process
9.2 Drug Coated Coronary Balloon Catheter Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Drug Coated Coronary Balloon Catheter Distributors
9.2.3 Drug Coated Coronary Balloon Catheter Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings